6monon MSN
According to the letter, the violations were related to Globus Medical’s (GMED) Class II Excelsius GPS (EGPS) surgical robot ...
Globus Medical reported third-quarter 2024 ... The growth was driven by increased sales within the U.S. market across its Excelsius GPS and E3D products. The reported figure also surpassed our ...
On August 13, 2024, the FDA published a warning letter to Globus Medical regarding an inspection of the Company’s Class II Excelsius GPS (EGPS) surgical robot, stating that the inspection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback